Aurora Cannabis Inc. (ACB)
| Market Cap | 249.54M |
| Revenue (ttm) | 238.84M |
| Net Income (ttm) | 1.58M |
| Shares Out | 56.25M |
| EPS (ttm) | 0.03 |
| PE Ratio | 150.81 |
| Forward PE | 37.54 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 209,473 |
| Open | 4.390 |
| Previous Close | 4.430 |
| Day's Range | 4.293 - 4.390 |
| 52-Week Range | 3.422 - 7.200 |
| Beta | 3.27 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 6, 2025 |
About X
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, c... [Read more]
Financial Performance
Financial StatementsNews
Cannabis Stocks Are at a Turning Point: Is Now the Time to Invest?
Currently, the cannabis industry is in another transitional period, presenting both challenges and potential opportunities for investors. After several years of volatility and downward trading, mariju...
Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting of Shareholders
Your vote is important no matter how many shares you own. Please vote today.
Aurora Cannabis to Host First Quarter 2026 Investor Conference Call
NASDAQ | TSX: ACB EDMONTON, AB , July 23, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, ann...
Here Is A Way Marijuana Stocks Can Make You A Return On Your Investment
This moment in time for marijuana stock investors could be the best opportunity. Legal cannabis is a volatile sector where MSO and ancillary companies are dominating it. Even with a drop in value for ...
Aurora Continues Deep Commitment to Veterans Through Strains for Heroes Initiative
The veteran-informed product line reinforces the company's patient-first approach NASDAQ | TSX: ACB EDMONTON, AB , July 16, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canad...
3 Top Canadian Marijuana Stocks To Watch As The Sector Looks To Bounce
2025 has been a troubled time for marijuana stock investors. With a lack of momentum and no sign of any upward trading, what are shareholders to do? Now, the cannabis industry outside of the public se...
Aurora Completes First-Ever EU-GMP Certification for the Company's Dedicated Distribution Centre
Adding a fourth certified facility within its global network increases operational capacity to better serve international medical markets NASDAQ | TSX: ACB EDMONTON, AB , July 14, 2025 /PRNewswire/ - ...
Aurora Cannabis Inc. (ACB) Announces Filing and Mailing of the Management Information
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce that the management information circular (the ...
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders
Your vote is important no matter how many shares you own. Please vote today.
Americans Should Buy Canadian Cannabis Companies
Canadian LPs offer compelling risk/reward versus U.S. cannabis stocks, with stronger balance sheets, tangible book value, and global opportunities due to federal legality. Despite recent rallies, Cana...
Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program NASDAQ | TSX: ACB EDMONTON, AB , June 26, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDA...
Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products
Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB , June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ...
Aurora Cannabis Falls On Weak 2026 Outlook Despite Record Q4 Revenues
Aurora Cannabis recently reported improved Q4-2025 results. ACB's international medical cannabis sales are increasing revenues. The company reported record revenues, but low gross profit and weak 2026...
3 Cannabis Stocks For Investors To Secure For Future Gains
The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, the...
Aurora Cannabis Advises of Second False Article from Investing.com
NASDAQ | TSX: ACB EDMONTON, AB , June 19, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has bec...
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics
NASDAQ | TSX: ACB EDMONTON, AB , June 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has bec...
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade)
Aurora Cannabis reported mixed Q4/FY2025 results, with higher-than-expected revenues offset by lower profitability due to a number of one-time expenses. Following substantial growth in recent quarters...
Aurora Cannabis Inc. (ACB) Q4 2025 Earnings Call Transcript
Aurora Cannabis Inc. (NASDAQ:ACB) Q4 2025 Earnings Conference Call June 18, 2025 8:00 AM ET Company Participants Kevin Niland - Corporate Participant Miguel Martin - CEO & Executive Chairman Simona K...
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline
Aurora Cannabis (ACB) shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S.
Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market
Canada-based medical marijuana company Aurora Cannabis Inc.'s ACB stock is trading lower after it released its fourth quarter 2025 earnings.
Aurora Cannabis Shares Fall on Polish Setback, Higher Costs in 4Q
Aurora Cannabis slid Wednesday morning after the company said regulatory headwinds in Poland hit prescription volumes and higher logistics costs pressured margins in the fiscal fourth quarter.
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining more than 50 points on Wednesday.
Aurora Cannabis 4Q Loss Narrows as Medical Cannabis Drives Revenue Beat
Aurora Cannabis's loss narrowed in its fiscal fourth quarter thanks to strong growth in its medical-cannabis business.
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter
NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue 1 of $244.4 million, representing 39% YoY growth Delivers Record Adjusted EBITDA 1 of $49.7 million, representing 261% YoY...
Aurora Cannabis: Poised For Its First Profitable Year
Aurora Cannabis is on track for its first profitable year, driven by a strategic pivot to high-margin medical cannabis and disciplined cost management. Strong international medical sales, improved mar...